Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19

The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of tropical medicine and hygiene 2020-10, Vol.103 (4), p.1590-1592
Main Authors: Lier, Audun J, Tuan, Jessica J, Davis, Matthew W, Paulson, Nathan, McManus, Dayna, Campbell, Sheldon, Peaper, David R, Topal, Jeffrey E
Format: Article
Language:English
Subjects:
Adrenal Cortex Hormones - administration & dosage
Aged
Animals
Anthelmintics - therapeutic use
Antibodies, Monoclonal, Humanized - administration & dosage
Betacoronavirus - pathogenicity
Case reports
Coinfection
Connecticut
Coronavirus Infections - drug therapy
Coronavirus Infections - immunology
Coronavirus Infections - parasitology
Coronavirus Infections - virology
Coronaviruses
COVID-19
Diabetes Mellitus - drug therapy
Diabetes Mellitus - immunology
Diabetes Mellitus - parasitology
Diabetes Mellitus - virology
Ecuador
Humans
Hypertension - drug therapy
Hypertension - immunology
Hypertension - parasitology
Hypertension - virology
Immunologic Factors - administration & dosage
Male
Pandemics
Peripheral Nervous System Diseases - drug therapy
Peripheral Nervous System Diseases - immunology
Peripheral Nervous System Diseases - parasitology
Peripheral Nervous System Diseases - virology
Pneumonia, Viral - drug therapy
Pneumonia, Viral - immunology
Pneumonia, Viral - parasitology
Pneumonia, Viral - virology
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Strongyloides stercoralis - pathogenicity
Strongyloidiasis - drug therapy
Strongyloidiasis - immunology
Strongyloidiasis - parasitology
Strongyloidiasis - virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following treatment with high-dose corticosteroids and tocilizumab. Screening for infection should be pursued in individuals with COVID-19 who originate from endemic regions before initiating immunosuppressive therapy.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.20-0699